Navigation Links
BioMarin Announces Third Quarter 2009 Financial Results
Date:10/28/2009

nder no obligation, and expressly disclaims any obligation to update or alter any forward-looking statement, whether as a result of new information, future events or otherwise.

BioMarin(®), Naglazyme(®) and Kuvan(®) are registered trademarks of BioMarin Pharmaceutical Inc.

Aldurazyme(®) is a registered trademark of BioMarin/Genzyme LLC.

                 BIOMARIN PHARMACEUTICAL INC. AND SUBSIDIARIES
                         CONSOLIDATED BALANCE SHEETS
              (In thousands, except for share and per share data)

                                                       December  September
                                                          31,        30,
                                                        2008 (1)    2009
                                                        --------    ----
                                                                 (unaudited)
                             ASSETS
      Current assets:
         Cash and cash equivalents                      $222,900   $191,778
         Short-term investments                          336,892    171,566
         Accounts receivable, net                         54,298     68,378
         Inventory                                        73,162     75,441
         Other current assets                             50,444     13,104
                                                          ------     ------

             Total current assets                        737,696    520,267
         Investment in BioMarin/Genzyme LLC                  915        522
         Long-term investments                             1,633    128,435
         Property, plant and equipment, net              124,979    182,099
         Intangible assets, net                            7,626      4,194
         Goodwill                                         21,262     21,262
         Other assets                                     12,584     12,578
        
'/>"/>
SOURCE  BioMarin Pharmaceutical Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 

Related medicine technology :

1. BioMarin to Present at the Oppenheimer Healthcare Conference
2. BioMarin Acquires Huxley Pharmaceuticals, Inc.
3. BioMarin Initiates Phase 2 Clinical Study of PEG-PAL in PKU
4. BioMarin Initiates Phase 1/2 Clinical Trial for GALNS for Morquio A Syndrome
5. BioMarin Announces Positive Results From Phase 2A Clinical Study of 6R-BH4 in Sickle Cell Disease
6. BioMarin Initiates Phase 1 Clinical Study of PEG-PAL in PKU
7. BioMarin Announces FDA Approval for Kuvan
8. BioMarin Partner AnGes MG, Inc. Submits BLA to Japanese Ministry of Health
9. Rigel Announces Presentations at Two Investor Conferences
10. Onyx Pharmaceuticals Announces Third Quarter 2009 Financial Results Teleconference and Webcast
11. STAAR Surgical Announces Third Quarter 2009 Earnings Release Date and Conference Call
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/16/2009)... WORTH, Texas, Dec. 16 Wound ... a rapidly growing provider of specialty medical ... operating subsidiary is moving toward productization of ... The company currently anticipates products to be ... market, estimated to be a multi-billion dollar ...
(Date:12/16/2009)... Inc. (OTC Bulletin Board: HEWA) an online U.S. mail-order ... 12% per annum short term debt financing. The ... of $500,000, with accrued interest and principal repayable in ... interest and principal repayable in one year from its ... for any calendar month prior to December 15, 2010. ...
(Date:12/16/2009)... International, well-known,scientific experts were ... (80 mg/day),data presented as "extremely promising."[1] ... and clinicians critically reviewed these data.,These ... generic lipid-modifying,treatments, fenofibrate and bezafibrate, in ... in patients with metabolic syndrome,and type ...
Breaking Medicine Technology:Wound Management Technologies, Inc. Targets Multi-Billion Dollar Biomaterials Market; Releases Update on Resorbable Orthopedics 2Wound Management Technologies, Inc. Targets Multi-Billion Dollar Biomaterials Market; Releases Update on Resorbable Orthopedics 3HealthWarehouse.com, Inc. Secures $1 Million in Debt Financing 2International, Well-Known Scientific Experts Say That New GFT505 Data Unlikely to Have the Potential to Affect the Established Role of Generic Fenofibrate and Bezafibrate in Managing Atherogenic Dyslipidemia 2International, Well-Known Scientific Experts Say That New GFT505 Data Unlikely to Have the Potential to Affect the Established Role of Generic Fenofibrate and Bezafibrate in Managing Atherogenic Dyslipidemia 3iSirona Announces Go live at University Hospitals in Cleveland 14887 1iSirona Announces Go live at University Hospitals in Cleveland 14887 2iSirona Announces Go live at University Hospitals in Cleveland 14887 3AMA Optics Announces New Brightness Acuity Meter Documents Disabling Glare from Cataract 61591 1AMA Optics Announces New Brightness Acuity Meter Documents Disabling Glare from Cataract 61591 2Deduplication Trend Eases the Strain of Medical Records Storage 61586 1Deduplication Trend Eases the Strain of Medical Records Storage 61586 2
... WIRE)--Apr 19, 2007 - Antares Pharma, Inc.,(AMEX: ... completed,site application study demonstrating that ANTUROL(R), it's,oxybutynin ... bioequivalent,basis after a single-dose was applied to ... an open-label, comparative three-way crossover,application site pharmacokinetic ...
... AACR Highlight Progress in SuperGen's,Oncology-Focused Pre-Clinical Pipeline, ... SuperGen,Inc. today announced that MP470, its multi-targeted ... critical component of,double- stranded DNA repair in ... of,presentations at the 2007 American Association for ...
Other Medicine Technology:Antares Pharma Announces Positive Results from Application Site,Study for Anturol 2Antares Pharma Announces Positive Results from Application Site,Study for Anturol 3Data Show SuperGen's Multi-Targeted Tyrosine Kinase Inhibitor,Suppresses Critical Double-Stranded DNA Repair Protein, Rad51 2Data Show SuperGen's Multi-Targeted Tyrosine Kinase Inhibitor,Suppresses Critical Double-Stranded DNA Repair Protein, Rad51 3Data Show SuperGen's Multi-Targeted Tyrosine Kinase Inhibitor,Suppresses Critical Double-Stranded DNA Repair Protein, Rad51 4Data Show SuperGen's Multi-Targeted Tyrosine Kinase Inhibitor,Suppresses Critical Double-Stranded DNA Repair Protein, Rad51 5Data Show SuperGen's Multi-Targeted Tyrosine Kinase Inhibitor,Suppresses Critical Double-Stranded DNA Repair Protein, Rad51 6Data Show SuperGen's Multi-Targeted Tyrosine Kinase Inhibitor,Suppresses Critical Double-Stranded DNA Repair Protein, Rad51 7
(Date:12/16/2009)... might not gain full benefit from breakthroughs, experts say, ... stem cell lines currently used for research come mostly ... That could mean that non-whites will benefit less from ... the line, experts say. , Blacks could be especially ... stem cell lines studied showed any traces of recent ...
(Date:12/16/2009)... most widely used human embryonic stem cell lines lack ... that must be addressed to ensure that all sectors ... a University of Michigan research team. ,, In the ... analyzed 47 embryonic stem cell lines, including most of ... scientists determined the genetic ancestry of each line and ...
(Date:12/16/2009)... role in reducing inflammation in the lungs , , WEDNESDAY, ... plays a role in inflammation seems to protect the ... who smoke. , Researchers also found that adult smokers ... lower risk of developing chronic obstructive pulmonary disease (COPD), ... "The gene seems to be protective of the lungs ...
(Date:12/16/2009)... Newborn-Safe Skin Care Products from Episencial Offers Planet-Friendly Organics, Solar-Powered ... , ... Los Angeles, CA (PRWEB) ... now have an authentic, affordable choice in all natural skin ... its eponymous product line for young children featuring the beloved ...
(Date:12/16/2009)... Neurological Stress Reduction Therapy or NSRTSM is found very effective ... such as allergies, asthma, migraines, chronic fatigue and a wide ... the country are using this holistic therapy including over 50 ... ... Minneapolis, MN (Vocus) December 14, 2009 -- BioVeda ...
Breaking Medicine News(10 mins):Health News:Most Stem Cells Used in Research Come From Whites 2Health News:U-M Study Reveals Surprising Lack of Genetic Diversity in the Most Widely Used Human Embryonic Stem Cell Lines 2Health News:U-M Study Reveals Surprising Lack of Genetic Diversity in the Most Widely Used Human Embryonic Stem Cell Lines 3Health News:U-M Study Reveals Surprising Lack of Genetic Diversity in the Most Widely Used Human Embryonic Stem Cell Lines 4Health News:U-M Study Reveals Surprising Lack of Genetic Diversity in the Most Widely Used Human Embryonic Stem Cell Lines 5Health News:Gene Variant Seems to Guard Against Asthma, COPD 2Health News:Gene Variant Seems to Guard Against Asthma, COPD 3Health News:New from Episencial: All Natural, Actively Healthy Skin Care for Babies, Kids and Planet Features Eric Carle's "The Very Hungry Caterpillar" 2Health News:New from Episencial: All Natural, Actively Healthy Skin Care for Babies, Kids and Planet Features Eric Carle's "The Very Hungry Caterpillar" 3Health News:New from Episencial: All Natural, Actively Healthy Skin Care for Babies, Kids and Planet Features Eric Carle's "The Very Hungry Caterpillar" 4Health News:New from Episencial: All Natural, Actively Healthy Skin Care for Babies, Kids and Planet Features Eric Carle's "The Very Hungry Caterpillar" 5Health News:BioVeda Health and Wellness Center of Chanhassen, MN Announces Its Grand Opening 2Health News:BioVeda Health and Wellness Center of Chanhassen, MN Announces Its Grand Opening 3Health News:BioVeda Health and Wellness Center of Chanhassen, MN Announces Its Grand Opening 4Health News:BioVeda Health and Wellness Center of Chanhassen, MN Announces Its Grand Opening 5
... becoming increasingly unhealthy, studies conducted have revealed.// ... or contain as much sugar as a bar of chocolate. ... sausages, two fried eggs or a McDonald's McBacon Roll. Two ... percent sugars. ,A study conducted by a ...
... of a skull and crossed bones as well detailed warnings ... said Tuesday. ,Every package of cigarette or any ... warning saying "Tobacco Kills" or "Smoking Kills", a pictorial representation ... ,The ministry warned that non-compliance of the new ...
... or neural tube defects in new borns has raised concern ... in Ireland should include folic acid, which is a way ... ,This would indeed help offsetting potential birth defects in children, ... do not take adequate folic acid supplements. Statistics has shown ...
... that keenly champions the battle against HIV /AIDS has ... which thwarts the efforts// put in by such organizations. ... at Human Rights Watch said “Twenty-five years into the ... feared and stigmatized. We can’t defeat AIDS unless we ...
... National Governors Association (NGA) has said in the new report ... of bird flu, then they have to get their// act ... to create public-private relationships, and to take time to train. ... at guiding the governors and other state leaders on their ...
... a pregnant woman, could be her body's way of telling her ... ,The study was carried out by researchers from the ... also studied their typical diets to understand if food ... suggests that morning sickness might have been nature's way of ensuring ...
Other Medicine News:Health News:Are Cereals A Health Hazard? 2Health News:The National Governors Association Releases Guidelines For Outbreak Of Bird Flu 2
Corning 7078 Calibrated"to deliver". multi-pack plugged capacity 5 mL...
... operative hysteroscopy, the surgeon and O.R. staff ... the dangers of fluid intravasation. Manual methods ... solution is the DOLPHIN II Fluid Management ... market leader in endoscopic irrigation. It has ...
... precision 4mL PYREX volumetric pipets ... Contain" (TC - bottom line) ... top line) to specifications for ... are color-coded with colored graduations ...
1000L...
Medicine Products: